• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病的多样性:全球不同种族非酒精性脂肪性肝病表现的综述

Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally.

作者信息

Han Ma Ai Thanda, Yu Qi, Tafesh Zaid, Pyrsopoulos Nikolaos

机构信息

Division of Gastroenterology and Hepatology, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.

出版信息

J Clin Transl Hepatol. 2021 Feb 28;9(1):71-80. doi: 10.14218/JCTH.2020.00082. Epub 2020 Dec 14.

DOI:10.14218/JCTH.2020.00082
PMID:33604257
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7868692/
Abstract

Globally, the rise in prevalence of obesity and metabolic syndrome as a whole has been linked to increased access to processed foods, such as refined sugars and saturated fats. Consequently, nonalcoholic fatty liver disease (NAFLD) is on the rise in both developed and developing nations. However, much is still unknown on the NAFLD phenotype with regards to the effect of ethnic diversity. Despite similarities in dietary habits, it appears that certain ethnicities are more protected against NAFLD than others. However, manifestations of the same genetic polymorphisms in different groups of people increase those individuals' predisposition to NAFLD. Diets from different regions have been associated with a lower prevalence of NAFLD and have even been linked to regression of hepatic steatosis. Socioeconomic variations amongst different regions of the world also contribute to NAFLD prevalence and associated complications. Thus, a thorough understanding of ethnic variability in NAFLD is essential to tailoring treatment recommendations to patients of different backgrounds.

摘要

在全球范围内,肥胖症和代谢综合征总体患病率的上升与食用加工食品(如精制糖和饱和脂肪)的机会增加有关。因此,非酒精性脂肪性肝病(NAFLD)在发达国家和发展中国家都呈上升趋势。然而,关于种族多样性对NAFLD表型的影响,仍有许多未知之处。尽管饮食习惯存在相似之处,但某些种族似乎比其他种族更能抵御NAFLD。然而,相同的基因多态性在不同人群中的表现会增加这些个体患NAFLD的易感性。来自不同地区的饮食与较低的NAFLD患病率相关,甚至与肝脂肪变性的消退有关。世界不同地区的社会经济差异也导致了NAFLD的患病率及相关并发症。因此,全面了解NAFLD中的种族变异性对于为不同背景的患者制定治疗建议至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca81/7868692/4fd11d50073e/JCTH-9-071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca81/7868692/4fd11d50073e/JCTH-9-071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca81/7868692/4fd11d50073e/JCTH-9-071-g001.jpg

相似文献

1
Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally.非酒精性脂肪性肝病的多样性:全球不同种族非酒精性脂肪性肝病表现的综述
J Clin Transl Hepatol. 2021 Feb 28;9(1):71-80. doi: 10.14218/JCTH.2020.00082. Epub 2020 Dec 14.
2
Nonobese Fatty Liver Disease.非肥胖性脂肪肝疾病。
Clin Gastroenterol Hepatol. 2017 Apr;15(4):474-485. doi: 10.1016/j.cgh.2016.08.028. Epub 2016 Aug 28.
3
Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review.非酒精性脂肪性肝病(NAFLD)中的基因多态性与多样性:一篇综述短文
Biomedicines. 2022 Dec 30;11(1):106. doi: 10.3390/biomedicines11010106.
4
Dietary approach in the treatment of nonalcoholic fatty liver disease.非酒精性脂肪性肝病治疗中的饮食方法。
World J Hepatol. 2015 Oct 28;7(24):2522-34. doi: 10.4254/wjh.v7.i24.2522.
5
Nonalcoholic fatty liver disease in Asia: emerging perspectives.亚洲的非酒精性脂肪性肝病:新视角。
J Gastroenterol. 2017 Feb;52(2):164-174. doi: 10.1007/s00535-016-1264-3. Epub 2016 Sep 16.
6
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的临床流行病学和疾病负担。
World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263.
7
Development of gene polymorphisms in meditators of nonalcoholic fatty liver disease.非酒精性脂肪性肝病冥想者基因多态性的发展
Biomed Rep. 2017 Aug;7(2):95-104. doi: 10.3892/br.2017.926. Epub 2017 Jun 14.
8
The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的流行病学、风险评估及诊断挑战
Medicines (Basel). 2019 Mar 18;6(1):41. doi: 10.3390/medicines6010041.
9
Practical approaches to the nutritional management of nonalcoholic fatty liver disease.非酒精性脂肪性肝病营养管理的实用方法
Integr Med Res. 2014 Dec;3(4):192-197. doi: 10.1016/j.imr.2014.09.003. Epub 2014 Sep 19.
10
Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.非酒精性脂肪性肝病瘦患者的特征:高血红蛋白水平的潜在作用。
Scand J Gastroenterol. 2015 Mar;50(3):341-6. doi: 10.3109/00365521.2014.983160. Epub 2014 Dec 26.

引用本文的文献

1
The relationship between liver stiffness, fat content measured by liver elastography, and coronary artery disease: a study based on the NHANES database.肝脏硬度、通过肝脏弹性成像测量的脂肪含量与冠状动脉疾病之间的关系:一项基于美国国家健康与营养检查调查(NHANES)数据库的研究。
Sci Rep. 2025 Aug 16;15(1):30010. doi: 10.1038/s41598-025-15709-y.
2
Forkhead box O1 in metabolic dysfunction-associated fatty liver disease: molecular mechanisms and drug research.叉头框O1在代谢功能障碍相关脂肪性肝病中的作用:分子机制与药物研究
Front Nutr. 2024 Jul 2;11:1426780. doi: 10.3389/fnut.2024.1426780. eCollection 2024.
3
Mapping global research trends: Nutrition associations with nonalcoholic fatty liver disease - a Scopus bibliometric analysis.

本文引用的文献

1
Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient-Reported Outcomes.非酒精性脂肪性肝炎所致晚期纤维化患者的疲劳与瘙痒:对患者报告结局的影响
Hepatol Commun. 2020 Aug 28;4(11):1637-1650. doi: 10.1002/hep4.1581. eCollection 2020 Nov.
2
Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome.脂肪肝综合征中肝纤维化的非侵入性检测(NITs)
Life (Basel). 2020 Sep 13;10(9):198. doi: 10.3390/life10090198.
3
Racial Disparities in Diagnosis and Prognosis of Nonalcoholic Fatty Liver Disease.
绘制全球研究趋势图:营养与非酒精性脂肪性肝病的关联——Scopus 文献计量分析。
World J Gastroenterol. 2024 Jun 28;30(24):3106-3119. doi: 10.3748/wjg.v30.i24.3106.
4
Supplementation of Micro- and Macronutrients-A Role of Nutritional Status in Non-Alcoholic Fatty Liver Disease.微量和宏量营养素的补充-营养状况在非酒精性脂肪性肝病中的作用。
Int J Mol Sci. 2024 Apr 30;25(9):4916. doi: 10.3390/ijms25094916.
5
Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome's effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017-2018.内脏和皮下腹部脂肪与非酒精性脂肪性肝病相关,同时增加代谢综合征对非酒精性脂肪性肝病的影响:NHANES 2017-2018 的横断面研究。
PLoS One. 2024 Feb 23;19(2):e0298662. doi: 10.1371/journal.pone.0298662. eCollection 2024.
6
Dietary patterns and metabolic dysfunction-associated fatty liver disease in China's multi-ethnic regions.中国多民族地区的饮食模式与代谢相关脂肪性肝病。
J Health Popul Nutr. 2023 Dec 13;42(1):141. doi: 10.1186/s41043-023-00485-0.
7
Association of nonalcoholic fatty liver disease with the different types of dietary carbohydrates: a cross-sectional study.非酒精性脂肪性肝病与不同类型膳食碳水化合物的关联:一项横断面研究。
J Diabetes Metab Disord. 2023 Jun 14;22(2):1139-1143. doi: 10.1007/s40200-023-01223-3. eCollection 2023 Dec.
8
Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review.非酒精性脂肪性肝病(NAFLD)中的基因多态性与多样性:一篇综述短文
Biomedicines. 2022 Dec 30;11(1):106. doi: 10.3390/biomedicines11010106.
9
Adherence to low carbohydrate diets and non-alcoholic fatty liver disease: a case control study.坚持低碳水化合物饮食与非酒精性脂肪性肝病:一项病例对照研究。
BMC Nutr. 2022 Nov 29;8(1):140. doi: 10.1186/s40795-022-00625-5.
10
Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review.种族和民族在非酒精性脂肪性肝病(NAFLD)中的作用:一项叙述性综述。
Nutrients. 2022 Oct 28;14(21):4556. doi: 10.3390/nu14214556.
非酒精性脂肪性肝病诊断与预后中的种族差异
Clin Liver Dis (Hoboken). 2020 Sep 4;16(2):66-72. doi: 10.1002/cld.948. eCollection 2020 Aug.
4
A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD.饮食策略在非酒精性脂肪性肝病(NAFLD)预防和治疗中的作用:是炒作还是确有实效?
Obesity (Silver Spring). 2020 Oct;28(10):1843-1852. doi: 10.1002/oby.22964. Epub 2020 Sep 6.
5
Real-World Burden of Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎的真实世界负担。
Clin Gastroenterol Hepatol. 2021 May;19(5):1020-1029.e7. doi: 10.1016/j.cgh.2020.06.064. Epub 2020 Jul 4.
6
Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.非酒精性脂肪性肝病患者的患者报告结局:慢性肝病问卷-非酒精性脂肪性肝病/非酒精性脂肪性肝炎的叙述性综述
J Gastroenterol Hepatol. 2021 Mar;36(3):629-636. doi: 10.1111/jgh.15172. Epub 2020 Jul 16.
7
Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis.血脂异常是非酒精性脂肪性肝炎患者肝纤维化进展的一个危险因素。
F1000Res. 2020 Jan 28;9:56. doi: 10.12688/f1000research.21918.1. eCollection 2020.
8
Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States.非酒精性脂肪性肝炎是美国肝移植增长最快的适应证。
Clin Gastroenterol Hepatol. 2021 Mar;19(3):580-589.e5. doi: 10.1016/j.cgh.2020.05.064. Epub 2020 Jun 9.
9
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.全球非肥胖或消瘦非酒精性脂肪性肝病的患病率、发病率和结局:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752. doi: 10.1016/S2468-1253(20)30077-7. Epub 2020 May 12.
10
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.代谢相关脂肪性肝病新定义:国际专家共识声明。
J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8.